Kenneth C. Anderson, MD

Kenneth C. Anderson, MD, is the Kraft Family Professor of Medicine at Harvard Medical School as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute.

Articles by Kenneth C. Anderson, MD

Multiple Myeloma Treatment Paradigm Improved Markedly In Recent Years

ByKenneth C. Anderson, MD

October 13th 2020

Kenneth C. Anderson, MD, discusses how he has seen the treatment paradigm transform over the last decade in multiple myeloma.

Highlighting Therapeutic Options in Later Lines for Multiple Myeloma

ByKenneth C. Anderson, MD

August 6th 2020

Kenneth C. Anderson, MD, discusses the therapies for patients who have multiple myeloma and have developed drug resistance.

Kenneth C. Anderson, MD

Articles by Kenneth C. Anderson, MD

Multiple Myeloma Treatment Paradigm Improved Markedly In Recent Years

Highlighting Therapeutic Options in Later Lines for Multiple Myeloma

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update

LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors

Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma